BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20583418)

  • 41. Survival factors after resection of small hepatocellular carcinoma.
    Wu FS; Zhao WH; Liang TB; Ma ZM; Teng LS; Wang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):379-84. PubMed ID: 16109520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of combined transarterial chemoembolization and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosis.
    Park MK; Gwak GY; Lim DH; Choo SW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2010; 57(101):801-6. PubMed ID: 21033233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
    Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
    Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
    Stuart KE; Anand AJ; Jenkins RL
    Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis.
    Carr BI; Irish W; Federle MP
    Hepatogastroenterology; 2010; 57(104):1375-81. PubMed ID: 21443089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
    Kulik LM; Carr BI; Mulcahy MF; Lewandowski RJ; Atassi B; Ryu RK; Sato KT; Benson A; Nemcek AA; Gates VL; Abecassis M; Omary RA; Salem R
    Hepatology; 2008 Jan; 47(1):71-81. PubMed ID: 18027884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
    Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
    Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis.
    Akinwande O; Kim D; Edwards J; Brown R; Philips P; Scoggins C; Martin RC
    Surg Oncol; 2015 Sep; 24(3):270-5. PubMed ID: 26133576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
    Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J
    Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes.
    Tanaka Y; Nakazawa T; Komori S; Hidaka H; Okuwaki Y; Takada J; Watanabe M; Shibuya A; Minamino T; Yamamoto H; Kokubu S; Hayakawa K; Koizumi W
    J Gastroenterol Hepatol; 2014 Feb; 29(2):352-7. PubMed ID: 23869689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Kim JY; Yoo EJ; Jang JW; Kwon JH; Kim KJ; Kay CS
    Radiat Oncol; 2013 Jan; 8():15. PubMed ID: 23324259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus.
    Cardarelli-Leite L; Chung J; Klass D; Marquez V; Chou F; Ho S; Walton H; Lim H; Tae Wan Kim P; Hadjivassiliou A; Liu DM
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):411-422. PubMed ID: 31909439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.
    Yu JI; Park HC; Lim DH; Park W; Yoo BC; Paik SW; Koh KC; Lee JH
    J Korean Med Sci; 2011 Aug; 26(8):1014-22. PubMed ID: 21860551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformal radiation therapy for hepatoma with portal vein thrombosis.
    Leung SW; Huang EY; Cheng YF; Lu SN
    Br J Radiol; 2000 May; 73(869):550-2. PubMed ID: 10884755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
    Li X; Ye Z; Lin S; Pang H
    BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
    Han KH; Seong J; Kim JK; Ahn SH; Lee DY; Chon CY
    Cancer; 2008 Sep; 113(5):995-1003. PubMed ID: 18615601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.